Respiratory syncytial virus is the leading cause of hospitalization among U.S. infants. A vaccine, nirsevimab, can reduce the ...

The United States is experiencing a rise in respiratory illnesses, commonly referred to as a “tripledemic,” involving ...

This time of year, Rhonda Williams from New Brunswick can be seen wearing a mask pretty much anywhere she goes. “It’s better ...

The respiratory syncytial virus (RSV) vaccine may not protect older adults who are immunocompromised as much as their healthier peers, according to new research.

RSV is "a common respiratory virus that infects the nose, throat, and lungs. RSV symptoms make it difficult to distinguish it ...

The risk of respiratory syncytial virus, or RSV, is on the rise, along with that of other illnesses including the flu, ...

Flu cases are surging across the commonwealth but for the youngest Pennsylvanians, another potentially dangerous respiratory ...

Common RSV symptoms include coughing, congestion, and headaches, as well as trouble eating, drinking, and swallowing. RSV ...

Vaccines to protect against respiratory syncytial virus (RSV) in newborns and older adults are being more widely accepted by ...

Influenza concentrations started to rise in November, and have continued to rise through December. RSV, or respiratory ...

Respiratory viruses including COVID-19, the flu, RSV and pneumonia are on the rise throughout Virginia, according to the ...

RSV and the flu have taken hold as Chicago residents have partaken in festivities in the last several weeks, and COVID is ...